Trending weight loss drugs such as Ozempic and Wegovy may be highly effective at tackling obesity, but are they also carrying ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

The S&P 500 rose 0.74% on Friday (April 25) to close at 5,525.21, extending its weekly gains as investors assessed global ...

GLP-1 drugs like Ozempic, while effective for significant weight loss and reducing chronic disease risk, are associated with ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...